Evidence map›Paper›PMID 42604904›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2026

Quantum Chemistry in Drug Design: Applications, Challenges, and the Need for Speed.

Christofer S Tautermann, Matthias Degroote, Benjamin Ries

Abstract readReview
PubMed Publisher
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christofer S TautermannDepartment of Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. christofer.tautermann@boehringer-ingelheim.com.
Matthias DegrooteQuantum Lab, Boehringer Ingelheim, Ingelheim am Rhein, Germany.
Benjamin RiesDepartment of Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantum mechanics (QM) provides a rigorous framework for modeling molecular interactions, making it increasingly valuable in drug design. However, its broader adoption is limited by computational cost and scalability. This manuscript reviews key QM applications-torsional profiles, spectra prediction, reactivity analysis, and modeling of non-covalent interactions-highlighting their impact and limitations. A detailed in-house study compares multiple methods across 3000 drug-like fragments, illustrating the trade-off between speed and accuracy. While machine learning and hybrid approaches offer faster alternatives, they often fall short of density functional theory (DFT) precision. The manuscript also explores scaling strategies and the emerging role of quantum computing. To fully leverage QM in drug discovery, faster and more scalable methods are essential.

Indexed as

Drug DesignQuantum MechanicsQuantum TheoryDrug DiscoveryModels, MolecularDrug designQuantum chemistryQuantum chemistry in drug designTorsion barriers

Identifiers

PMID42604904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.